Filters

A S Cross
S M Opal

JAMA

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
JAMA|June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study GroupC J Fisher, J F Dhainaut, S M Opal, et al.
JAMA|October 26, 2001
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trialB L Warren, A Eid, P Singer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JAMA|September 8, 1993
The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.
JAMA|June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study GroupC J Fisher, J F Dhainaut, S M Opal, et al.
JAMA|October 26, 2001
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trialB L Warren, A Eid, P Singer, et al.
Pageof 1
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us